ProShare Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $270M | Buy |
1,073,381
+34,281
| +3% | +$7.38M | 0.39% | 34 |
|
|
2026
Q1 | $226M | Buy |
1,039,100
+6,126
| +0.6% | +$1.36M | 0.33% | 41 |
|
|
2025
Q4 | $236M | Sell |
1,032,974
-156,611
| -13% | -$35.7M | 0.42% | 43 |
|
|
2025
Q3 | $275M | Sell |
1,189,585
-25,387
| -2% | -$5.17M | 0.58% | 21 |
|
|
2025
Q2 | $226M | Sell |
1,214,972
-67,522
| -5% | -$12.5M | 0.45% | 39 |
|
|
2025
Q1 | $269M | Buy |
1,282,494
+20,001
| +2% | +$3.89M | 0.61% | 27 |
|
|
2024
Q4 | $224M | Buy |
1,262,493
+10,064
| +0.8% | +$1.85M | 0.51% | 37 |
|
|
2024
Q3 | $247M | Sell |
1,252,429
-57,255
| -4% | -$10.7M | 0.61% | 30 |
|
|
2024
Q2 | $225M | Buy |
1,309,684
+26,088
| +2% | +$4.32M | 0.6% | 28 |
|
|
2024
Q1 | $234M | Sell |
1,283,596
-50,834
| -4% | -$8.76M | 0.62% | 29 |
|
|
2023
Q4 | $207M | Sell |
1,334,430
-203,257
| -13% | -$29.6M | 0.63% | 34 |
|
|
2023
Q3 | $229M | Buy |
1,537,687
+192,632
| +14% | +$28.3M | 0.71% | 22 |
|
|
2023
Q2 | $181M | Sell |
1,345,055
-98,385
| -7% | -$14.4M | 0.53% | 57 |
|
|
2023
Q1 | $230M | Buy |
1,443,440
+108,304
| +8% | +$16.6M | 0.7% | 19 |
|
|
2022
Q4 | $216M | Buy |
1,335,136
+9,677
| +0.7% | +$1.48M | 0.76% | 23 |
|
|
2022
Q3 | $178M | Sell |
1,325,459
-27,073
| -2% | -$3.88M | 0.68% | 26 |
|
|
2022
Q2 | $207M | Sell |
1,352,532
-207,457
| -13% | -$31.7M | 0.69% | 23 |
|
|
2022
Q1 | $253M | Sell |
1,559,989
-191,538
| -11% | -$27.8M | 0.54% | 29 |
|
|
2021
Q4 | $237M | Buy |
1,751,527
+238,062
| +16% | +$28.1M | 0.47% | 35 |
|
|
2021
Q3 | $163M | Buy |
1,513,465
+13,266
| +0.9% | +$1.52M | 0.46% | 50 |
|
|
2021
Q2 | $169M | Buy |
1,500,199
+220,847
| +17% | +$24.9M | 0.49% | 36 |
|
|
2021
Q1 | $138M | Sell |
1,279,352
-182,306
| -12% | -$19.5M | 0.44% | 46 |
|
|
2020
Q4 | $157M | Buy |
1,461,658
+270,318
| +23% | +$26M | 0.58% | 27 |
|
|
2020
Q3 | $104M | Buy |
1,191,340
+12,882
| +1% | +$1.21M | 0.48% | 52 |
|
|
2020
Q2 | $116M | Sell |
1,178,458
-216,761
| -16% | -$19.1M | 0.62% | 26 |
|
|
2020
Q1 | $106M | Sell |
1,395,219
-286,839
| -17% | -$24.4M | 0.76% | 20 |
|
|
2019
Q4 | $149M | Buy |
1,682,058
+15,161
| +0.9% | +$1.26M | 0.69% | 26 |
|
|
2019
Q3 | $126M | Buy |
1,666,897
+351,803
| +27% | +$24.1M | 0.71% | 23 |
|
|
2019
Q2 | $95.6M | Buy |
1,315,094
+199,885
| +18% | +$15.7M | 0.57% | 41 |
|
|
2019
Q1 | $89.9M | Sell |
1,115,209
-28,621
| -3% | -$2.34M | 0.54% | 44 |
|
|
2018
Q4 | $105M | Buy |
1,143,830
+130,976
| +13% | +$11.5M | 0.74% | 22 |
|
|
2018
Q3 | $95.8M | Buy |
1,012,854
+45,870
| +5% | +$4.35M | 0.65% | 28 |
|
|
2018
Q2 | $89.6M | Buy |
966,984
+5,950
| +0.6% | +$581K | 0.6% | 29 |
|
|
2018
Q1 | $91M | Sell |
961,034
-56,042
| -6% | -$6.16M | 0.59% | 30 |
|
|
2017
Q4 | $98.4M | Sell |
1,017,076
-19,147
| -2% | -$1.8M | 0.68% | 24 |
|
|
2017
Q3 | $92.1M | Sell |
1,036,223
-86,463
| -8% | -$6.58M | 0.85% | 15 |
|
|
2017
Q2 | $81.4M | Sell |
1,122,686
-6,768
| -0.6% | -$455K | 0.81% | 15 |
|
|
2017
Q1 | $73.6M | Buy |
1,129,454
+74,621
| +7% | +$4.69M | 0.77% | 20 |
|
|
2016
Q4 | $66.1M | Buy |
1,054,833
+94,630
| +10% | +$5.78M | 0.73% | 23 |
|
|
2016
Q3 | $60.6M | Buy |
960,203
+72,252
| +8% | +$4.68M | 0.85% | 20 |
|
|
2016
Q2 | $55M | Buy |
887,951
+221,988
| +33% | +$13.5M | 0.71% | 28 |
|
|
2016
Q1 | $38M | Sell |
665,963
-56,093
| -8% | -$3.13M | 0.52% | 34 |
|
|
2015
Q4 | $42.8M | Buy |
722,056
+187,507
| +35% | +$10.8M | 0.52% | 36 |
|
|
2015
Q3 | $29.1M | Buy |
534,549
+4,740
| +0.9% | +$309K | 0.41% | 51 |
|
|
2015
Q2 | $35.6M | Sell |
529,809
-4,437
| -0.8% | -$290K | 0.49% | 37 |
|
|
2015
Q1 | $31.3M | Buy |
534,246
+24,871
| +5% | +$1.5M | 0.37% | 54 |
|
|
2014
Q4 | $33.3M | Buy |
509,375
+131,645
| +35% | +$8.3M | 0.39% | 48 |
|
|
2014
Q3 | $21.8M | Sell |
377,730
-17,663
| -4% | -$981K | 0.29% | 62 |
|
|
2014
Q2 | $22.3M | Buy |
395,393
+14,481
| +4% | +$760K | 0.29% | 59 |
|
|
2014
Q1 | $19.6M | Buy |
380,912
+43,370
| +13% | +$2.19M | 0.24% | 67 |
|
|
2013
Q4 | $17.8M | Buy |
337,542
+179,339
| +113% | +$8.81M | 0.27% | 67 |
|
|
2013
Q3 | $7.08M | Sell |
158,203
-101,802
| -39% | -$4.51M | 0.17% | 93 |
|
|
2013
Q2 | $10.7M | Buy |
+260,005
| New | +$11.4M | 0.21% | 84 |
|
Other funds holding ABBV
ProShare Advisors's ABBV Position: Q2 2026 in Review
ProShare Advisors increased its AbbVie (ABBV) stake by 3.3% in Q2 2026, buying an estimated $7.38M and bringing the position to 1,073,381 shares worth $270M. The position accounts for 0.39% of the portfolio, ranked #34.
ProShare Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $275M in Q3 2025. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- ProShare Advisors held 1,073,381 shares of AbbVie worth $270M as of Q2 2026.
- ProShare Advisors bought 34,281 AbbVie shares in Q2 2026, an estimated $7.38M.
- AbbVie made up 0.39% of ProShare Advisors's portfolio in Q2 2026, its #34 holding.
- ProShare Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- ProShare Advisors's AbbVie position peaked at $275M in Q3 2025.
- 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.